Viberzi (eluxadoline): Drug Safety Communication - Increased Risk of Serious Pancreatitis In Patients Without A Gallbladder
Date of publication: 15-03-2017
Patients who do not have a gallbladder should not take Viberzi. Developing pancreatitis could result in hospitalization or death. Źródło: http://www.fda.gov
